HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Human epidermal growth factor receptor 2 (HER2) protein overexpression and/or HER2 gene amplification is found in about 20% of invasive breast cancers. It is a sole predictive marker for treatment benefits from HER2 targeted therapy and thus, HER2 testing is a routine practice for newly diagnosed br...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2020-01-01
|
| Σειρά: | Journal of Pathology and Translational Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.jpatholtm.org/upload/pdf/jptm-2019-11-03.pdf |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|